Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, Ontario M5S 3M2, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, 164 College Street, Toronto, Ontario M5S 3E1, Canada.
Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, Ontario M5S 3M2, Canada.
Int J Pharm. 2014 Apr 10;464(1-2):168-77. doi: 10.1016/j.ijpharm.2014.01.010. Epub 2014 Jan 17.
While the heightened tumor accumulation of systemically administered nanomedicines relative to conventional chemotherapeutic agents has been well established, corresponding improvements in therapeutic efficacy have often been incommensurate. This observation may be attributed to the limited exposure of cancer cells to therapy due to the heterogeneous intratumoral distribution and poor interstitial penetration of nanoparticle-based drug delivery systems. In the present work, the spatio-temporal distribution of block copolymer micelles (BCMs) of different sizes was evaluated in multicellular tumor spheroids (MCTS) and tumor xenografts originating from human cervical (HeLa) and colon (HT29) cancer cells using image-based, computational techniques. Micelle penetration was found to depend on nanoparticle size, time as well as tumor and spheroid cell line. Moreover, spheroids demonstrated the capacity to predict relative trends in nanoparticle interstitial transport in tumor xenografts. Overall, techniques are presented for the assessment of nanoparticle distribution in spheroids and xenografts and used to evaluate the influence of micelle size and cell-line specific tissue properties on micelle interstitial penetration.
虽然已充分证实,与传统化疗药物相比,全身性给予的纳米药物会引起肿瘤蓄积增加,但治疗效果的相应改善往往并不相称。这种观察结果可能归因于由于纳米粒给药系统在肿瘤内的分布不均匀和间质渗透不良,癌细胞与治疗的接触有限。在本工作中,使用基于图像的计算技术,评估了不同大小的嵌段共聚物胶束(BCMs)在多细胞肿瘤球体(MCTS)和源自人宫颈(HeLa)和结肠(HT29)癌细胞的肿瘤异种移植物中的时空分布。胶束渗透取决于纳米颗粒大小、时间以及肿瘤和球体细胞系。此外,球体显示出预测肿瘤异种移植物中纳米颗粒间质传输相对趋势的能力。总之,提出了用于评估球体和异种移植物中纳米颗粒分布的技术,并用于评估胶束大小和细胞系特定组织特性对胶束间质渗透的影响。